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Persistent organic pollutants (POPs), such as polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs), polychlori-
nated biphenyls (PCBs), and polybrominated ethers (PBDEs), chloronaftalens (PCNs), and bisphenol A (BPA), are stable, lipophilic
pollutants that affect fertility and cause serious reproductive problems, including ovotoxic action, lack of ovulation, premature
ovarian failure (POF), or polycystic ovarian syndrome (PCOS). Most of the representatives of POPs influence the activation of
transcription factors, not only activation of aromatic hydrocarbon receptor (AhR), but also the steroid hormone receptors. This
minireview will focus on a variety of PAH activities in oocyte, ovary, placenta, and mammary gland. The complexity and diversity
of factors belonging to POPs and disorders of the reproductive function of women indicate that the impact of environmental
pollution as an important determinant factor in fertility should not be minimize.
1. Introduction
For the past decade, scientists, institutions, governments, and
policymakers have warned the general public about serious
health hazards associatedwith chemicals known as endocrine
disruptors (EDs). EDs are exogenous compounds that inter-
fere with the synthesis, secretion, transport, metabolism,
and/or action of endogenous hormones that are responsible
for normal homeostasis, reproduction, and development.
Chemicals with hormonal activity can be divided into three
main groups: (i) synthetic compounds used in industry and
agriculture as well as in consumer products, (ii) synthetic
compounds used in pharmaceutical drugs, and (iii) natural
compounds present in the food chain (i.e., phytoestrogens,
compounds that are structurally similar to estrogen (E2)).
Only (i) synthetic compounds used in industry and agri-
culture and consumer products will be discussed in pre-
sented paper. Within this class, compounds can be fur-
ther subcategorized into those that are persistent in all ele-
ments of the environment, bio-accumulative, transporta-
ble over long distances, and capable of adversely affect-
ing life forms that reside within short and long distances
from the site of contamination. These compounds include
dichlorodiphenyltrichloroethane (DDT, a pesticide), poly-
chlorinated biphenyls (PCBs), polychlorinated naphthalenes
(PCNs), polychlorinated dibenzodioxins (PCDDs), poly-
chlorinated dibenzofurans (PCDFs), and polybrominated
diphenyl ethers (PBDEs) (Figure 1).
Because xenobiotics can accumulate in the body for an
extremely long period of time (i.e., decades), they can be
detrimental to human health even at very low doses. For
instance, pesticides and other synthetic compounds used in
the 1950s have polluted the air that we breathe, the water that
we drink, and the soil that we grow our food in. In addition,
many of these compounds are nonbiodegradable. Studies
have shown the presence of EDS both in adipose tissue
and other organs, in almost all humans and many animals.
Human exposure to environmental toxicants is mediated via
food and water chains, breathing, and dermal absorption,
with approximately 90% of the exposure coming from food.
Moreover, several mammalian organs (e.g., ovary, breast,
uterus, cervix, bone, muscle, and skin) rely on sex steroids for
normal function, and these organs are especially vulnerable
to endocrine disruption by environmental toxicants. This


























Figure 1: Generic structure of the (a) DDT, (b) PCBs, (c) PCNs, (d)
PCDDs, (e) PCDFs, and (f) PBDEs.
chapter will focus only on selected actions or abnormalities.
Much of the information on the impact of EDs on human
health has come from in vivo studies where animals were
exposed to a single compound, usually at an acute (i.e.,
pharmacological) dose; however, humans are exposed to
several compounds at unknown concentrations for unknown
durations. For example, hospital patients receive an average
of six drugs daily (i.e., aspirin, antihistamines, antibiotics,
anti-cough syrup, etc.). Food and water may also contain low
levels of organic and inorganic compounds (e.g., pesticides
and heavy metals) and solvents (e.g., benzene, toluene, and
chloroform), and air is filledwith hundreds of chemicals (e.g.,
industrial pollutants, smoke, gasoline vapors, etc.).The ability
of these environmental toxicants to affect human health
depends on several factors, including interactions between
compounds; absorption, metabolism, accumulation, and
excretion of compounds; and the ability of some compounds
bind to cell receptors which can affect hormone action.
Unfortunately, little is known about how these environmental
toxicants interact with each other existing in a mixture. It is
known that such xenobiotic acts in different ways depending
on whether their action is observed on the fetus, newborn
babies, or adult individuals, depending on the period during
whose body has been exposed to these factors. Inmany cases,
the effect of their actions may be undetected until sexual
maturity, especially when exposure occurs during a period
of embryonic development or shortly after birth. The female
reproductive cycle is a complex process comprised of game-
togenesis, embryogenesis, menstruation, ovulation, possi-
ble pregnancy, endometrial, and mammary gland changes.
Development of the female reproductive system during fetal
life determines reproductive success. Women are born with
all the oocytes they will ever have through their life, and
therefore oocytes aremore vulnerable to toxic chemicals than
germ cells in men who continue to make more germ cells.
2. Actions on the Oocyte
Oocyte maturation, the final step of germ cell differentiation,
determines reproductive capacity. Follicles are especially sus-
ceptible to the adverse effects of environmental toxicants, and
developing oocytes may be damaged directly or indirectly
by action on follicular cells (i.e., granulosa cells) that may
also be vulnerable to endocrine disruption, thereby affecting
oocyte function indirectly. A previous study illustrated that
human oocytes harvested from follicles with elevated levels
of polycyclic aromatic hydrocarbons (PCAHs) had fewer
cell divisions after in vitro fertilization [1]. Chloroorganic
mixtures such as PCBs and DDT, as well as its metabolites,
have also been reported to affect puberty, development, and
oocyte viability adversely [2]. Some of these studies point
to unpredictable changes of translational regulation within
the oocyte under the influence of PCBs [3]. Polyspermia
(secretion of an excessive amount of semen) has also been
demonstrated in cattle exposed to an environmentally rele-
vant mixture of more than 15 organochlorines [4]. Presently,
additional research is needed to better understand themolec-
ular mechanisms behind mammalian ovotoxicity caused by
exposure to environmental toxicants.
Ovarian function is controlled by the hypothalamus, pitu-
itary, and autoparacrine factors. Hormone-mimicking com-
pounds can bind to cell receptors, interfere with hormone
action, and affect ovarian function. How EDs affect ovarian
function is not yet clear, but a disruption in gonadotropin
(i.e., follicle stimulating hormone (FSH) and luteinizing hor-
mone (LH)) secretion and feedback mechanisms involving
E2 and progesterone (P4) may be involved. Alternatively,
EDs may affect ovarian hormone production and oocyte
maturation. Damaged oocytes can affect overall hormone
production and follicular function, resulting in an endocrino-
logical imbalance (i.e., a decrease in E2 and P4, but an
increase in FSH and LH) and ovarian failure.
3. Actions on the Ovary
3.1. Disruption of Ovarian Function. Fertility in sexually
mature women depends largely on the maintenance of
healthy follicles, and their steady production ensures that
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an adequate number of follicles reach the antral stage. The
stage of development at which the follicles are destroyed
determines the influence of these factors on the fertility of
women. Complete depletion of the follicle reserve results in
irreversible infertility; partial depletion of the follicle reserve
results in moderate effects on periodicity. Damage to large
follicles can also lead to reversible acyclic disorders that affect
hormone production and ovulation. Nevertheless, the effects
of POPs on the hypothalamic-pituitary-ovarian (HPO) axis
are generally reversible because they do not permanently
affect the follicle reserve.
3.1.1. TCDD. TCDD (2, 3, 7, 8-teterachlorodibenzo-para-
dioxin) is an isomer of PCDD, and one of the most toxic
man-made compounds to pollute our environment. Studies
on themechanism of TCDD action during ovulation indicate
a dysfunction in the HPO axis. Misregulation of FSH and
LH secretion before ovulation was noted in rats exposed to
TCDD.Moreover, gonadotropin-releasing hormone (GnRH)
inhibited the surge in FSH and LH secretion, thereby restor-
ing ovulation [5, 6]. TCDD also inhibited FSH secretion
and downregulated FSH receptor gene expression [7]. TCDD
affected the levels of other hormones as well. For instance,
Gore [8] showed methoxychlor to affect GnRH expression
in hypothalamic GT1-7 cells. In a study from our laboratory,
TCDD inhibited E2 secretion by follicular cells and P4 secre-
tion by luteal cells dose-dependently. These adverse effects
on hormone production were mediated in part by enzymes
involved in steroidogenic biosynthesis. In luteal cells, TCDD
action was independent of E2 receptor stimulation, instead
involving the aryl hydrocarbon receptor (AhR) [9]. On a final
note, other environmental toxicants (i.e., PCDFs, biphenyls,
DDT, and methoxychlor) can also block the surge in LH and
FSH secretion during the female reproductive cycle [10, 11].
3.1.2. PCBs. Polychlorinated biphenyls (PCBs) are the man-
made chemicals that may disrupt follicular steroidogenesis
either by mimicking natural hormones as agonist or antag-
onist, altering the pattern of hormone synthesis, modulat-
ing hormone receptor affinities or numbers, or by altering
enzymes involved in hormone secretion. In our previous
study, we showed that the orthosubstituted PCB 153 congener
accumulated preferentially in the follicular wall when com-
pared to the nonorthosubstituted PCB 126 congener. 71%,
71.4%, and 30.4% of the total exposure for PCB 153 were
in small, medium, and large follicles, respectively (Figure 1).
Interestingly, about 70% of PCB153 accumulated in early
antral and antral follicles and only 30% in preovultory fol-
licles.The consequence was a reduction in estradiol secretion
by early antral and antral follicles and lack of influence on
estradiol secretion by preovulatory follicles. Moreover, More-
over, it has been showed that action on estradiol secretionwas
correlatedwith action on aromatase activity [12–14]. A similar
dose-responsive relationship was reported after exposure of
follicular cells to a mixture of organic pollutants [15] or a
mixture of PBDEs [16].
3.1.3. PBDEs. Polybrominated dibenzoethers (PBDEs) are
persistent and ubiquitous environmental toxicants found at
increasing levels in humans and animals. Despite recent bans
by the European Union [17], United States, and China on
the production of penta- and octa-BDE as well as on the
diminished use of PBDE in Japan [18], 2,2󸀠,4,4󸀠-tetra-BDE
(BDE-47), 2,2󸀠,4,4󸀠,5-penta-BDE (BDE-99), and 2,2󸀠,4,4󸀠,6-
penta-BDE (BDE-100) are themajor PBDE congeners present
in humans and animals [19]. The literary data related to the
effects of PBDE mixture are limited predominantly to com-
mercial mixture DE-71 which contains mainly penta-BDEs
(BDE-99 and BDE-100) and tetra-BDE (BDE-47). Zhou et al.
[20] and Stoker et al. [21] indicated that DE-71 (a mixture of
BDE-99, BDE-100, and tetra-BDE) affected the production of
thyroid and sex steroids and the development of reproductive
organs [20, 21]. Results from our laboratory have shown
an increase in the P4/testosterone (T) ratio but a decrease
in the T/E2 ratio, in ovarian follicles suggesting premature
luteinization of antral follicles. Removal of the PBDEmixture
from cell cultures did not reverse adverse effects [22]. In a
follow-up study, we reported changes in the levels of steroido-
genic enzymes (e.g., 17𝛽-hydroxysteroid dehydrogenase (17𝛽-
HSD), cytochrome P450, family 17, subfamily A, polypeptide
1 (CYP17), and aromatase (CYP19)) by PBDE congeners 47,
99, and 100 [23]. Last published data showed fast activation
of CYP2B1/2, and late activation of COMT (with a very
low basal SULT1A activity) in ovarian follicles by BDE-47
indicates a possible action of locally produced hydroxylated
metabolites prior to their detoxification [24]. Additionally,
it have been showed that 5-OH-BDE-47 and 6-OH-BDE-47
have a different mechanism of action in ovarian follicles from
their parent compound and lead to an increase in estradiol
secretion. The metabolites stimulate aromatase expression
and activity, while the parent compound increases androgen
production and stimulation of 17𝛽-HSD protein expression
and activity [25].
3.1.4. PCNs. Polychlorinated naphthalenes (PCNs) are mem-
bers of a large and diverse group of compounds with several
industrial applications. PCNs occur as mixtures of congeners
sold under various trade names (e.g., Halowax, Nibren Wax,
and Seekay Wax) [26]. The toxicological characteristics of
PCNs are similar to those caused by PCBs, PCDDs, and
PCDFs [27, 28]. Presently, there are little data on the toxicity
of PCNs in experimental animals, and our recently published
data was the first showed direct action on ovarian function.
We showed an increase in basal testosterone secretion in all
doses used, with the highest stimulatory action of the smallest
dose, which was accompanied by a parallel decrease in
basal estradiol secretion, induced byHalowax 1051 suggesting
androgenic properties of Halowax 1051. As a mechanism we
propose direct stimulatory action on 17𝛽-HSD activity and
protein expression, enzyme responsible for testosterone syn-
thesis and inhibitory action on CYP19 activity, and enzyme
responsible for conversion testosterone to estradiol [29]. It
should be taken into consideration that as in the case of BDE-
47 [24], the effects of exposure to PCNs may be due to the
side effects of PCN metabolites. Examining the effects of the
Halowax 1051 on phase I (CYP1A1) and phase II (SULT1A and
COMT) enzyme activities and expression in cultured ovarian
follicles we showed fast activation of enzymes involved in
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phase I and concurrent inhibition of enzymes involved in
phase II metabolism confirming our suggestion that the
observed effects of Halowax 1051 are partially result from the
action of metabolites formed locally in ovarian follicles [30].
3.1.5. HCBz. Data on the effects of hexachlorobenzene
(HCBz) on reproduction are scant. While HCBz is toxic to
humans [31, 32] and animals [33], information on the effects
of HCBz in ovarian steroidogenesis is limited despite data
that showed an increase in the P4 serum level in superovu-
lated rats exposed to HCBz [34]. Treatment of Cynomolgus
monkeys with HCBz, on the other hand, decreased the P4
serum level and unaltered the E2 serum level during the
luteal phase. In a recently published study, we determined
in vitro accumulation of hexachlorobenzene (HCBz) and
pentachlorobenzene (PeCBz) in porcine ovarian follicles, the
effect on steroidogenesis, and the expression of enzymes
responsible for steroid synthesis [35]. We showed that sixty
percent of the HCBz and almost 100% of the PeCBz that was
added to the culture medium accumulated in ovarian tissue,
and only 1% of each was found in the medium. Moreover, we
showed inhibitory HCBz effect and stimulatory PeCBz effect
on testosterone and estradiol secretion. As a conclusion we
mentioned that the greater exposure to an estrogenic action
of PeCBz than antiestrogenic HCBz would be a consequence
of the preferential accumulation of PeCBz in the ovarian
follicles. Another situation was observed in human placental
tissue. BothHCBz and PeCBz did not accumulate in placental
tissue. We showed that HCBz by fast activation of I and
II phase metabolism is probably metabolized to PeCBz in
placental tissue (Gregoraszczuk et al., unpublished data).
3.1.6. A Mixture of Environmental Toxicants. Toxicants usu-
ally occur in a mixture of several toxicants, making it difficult
to predict adverse effects onhumanhealth. Younglai et al. [36]
demonstrated human follicular fluid obtained from women
to contain 1, 1-dichloro-2, 2-bis (p-chlorophenyl)-ethylene
(p, p󸀠-DDE), mirex (a pesticide), hexachloro-ethane 1, 2, 4-
trichlorobenzene, and numerous PCBs (i.e., PCBs 49, 153, and
180). Of these, p, p󸀠-DDE was the most frequently detected
ED in follicular fluid and serum. Several environmental
toxicants are ER agonists, and they include estrogenic steroids
(natural and synthetic), phyto- and mycoestrogens, and
xenoestrogens (e.g., pesticides, plasticizers, and alkylphe-
nols). In addition to simple additive effects [37], interactions
between different chemicals in a mixture may result in either
a weaker (antagonistic) [38] or stronger (synergistic, poten-
tiated) combined effect than would be expected from knowl-
edge about the toxicity andmode of action of each individual
compound. These interactions may occur during toxicant
uptake, distribution, metabolism, and/or excretion (i.e., tox-
icokinetic phase), or during toxicant binding to receptors
and cellular targets (i.e., toxicodynamic phase) [39, 40]. A
mixture of xenoestrogens may alter the way a cell responds to
endogenous estrogens. For instance, xenoantiestrogens found
within mixtures can inhibit endogenous E2. Moreover, some
estrogenic compounds exert their effects, not by binding
to ER but rather by binding to estrogen plasma transport
proteins, resulting in an increase in free endogenous E2.
Nevertheless, mixtures containing both xenoestrogens and
endoantiestrogens may have no adverse effects [41]. In our
previously published data, to determine which compounds
within a PCB-DDT-DDE mixture stimulated E2 secretion,
we exposed cells to PCBs 118, 138, 153, and 180, DDT, and
DDE alone or in different combinations. Interestingly, DDT
and DDE affected E2 secretion [42], and these results are
in agreement with another series of experiments that used
mixtures of PBDEs [43]. In the next experiments, using
Western blot analysis indicated that PCBs mixture (“Marine
mix”) is an inducer of AhR and mixed-type CYP inducer
(CYP1A1 and CYP2B1) while PBDEs mixture (“Mjosa mix”)
is an inducer of ER𝛽 and CYP2B [44].
3.2. Pathology of the Ovary
3.2.1. Early Puberty. Early puberty is a recent growing con-
cern as there are reports of many girls reaching their first
menstruation and developing breasts earlier in life than was
the case 40 years ago [45]. Early puberty associates with
polycystic ovarian syndrome (PCOS), obesity, breast cancer,
depression, and a number of social challenges such as exper-
imentation with sex, alcohol, or drugs at a younger age.
Moreover, earlier menarche and thelarche ages have been
reported in girls after exposure to PCBs, PBBs, DDT, and/or
phthalate esters [46, 47], and precocious puberty has been
observed following exposure to DDT metabolites [48].
3.2.2. Polycystic Ovarian Syndrome (PCOS). The acyclicity
of the syndrome is linked with the hyperfunctioning of
theca and hypofunctioning of granulosa cells. PCOS also
associates with other processes (e.g., neuroendocrine func-
tion and ovarian steroidogenesis) and diseases (e.g., insulin
resistance, and obesity) that are regulated by hormonal and
metabolic factors.Thus, exposure to environmental toxicants
may indeed contribute to the pathogenesis of PCOS. For
instance, women with PCOS have higher levels of bisphenol
A (BPA, a plastics additive) [49] and testosterone which is
consistent with the decreased clearance of BPA that is often
observed [50]. Although a cause-and-effect relationship has
not been established, the role of environmental toxicants in
the pathogenesis of PCOS is worthy of further consideration.
3.2.3. Premature Ovarian Failure (POF). POF, the cessation
of normal ovarian function before the age of 40, occurs in
approximately 1% of women of reproductive age [51]. The
underlying causes of POF are largely known in most cases,
and any factor that can decrease the ovarian reserve can result
in POF. For instance, disruption of germ cell migration from
the genital ridge to the developing gonad results in ovarian
dysgenesis and POF. In addition, adult and in utero exposure
of mice to BPA resulted in oocyte damage [52, 53], whereas
exposure of women to cigarette smoke decreased fertility, in
vitro fertilization (IVF) success rates, and the ovarian reserve
resulted in earlier menopause and increased miscarriage
rate [54]. In another study, exposure of rats to TCDD in
utero and throughout reproductive life resulted in premature
reproductive senescence [55]. Endocrine disruption caused
by acute exposure to environmental toxicants such as the
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AhR agonist TCDD suggests that AhR-mediated apoptosis of
oocytes may be involved.
4. Hormone-Dependent Cancer
4.1. Breast Cancer. Breast cancer is the most frequent neo-
plasm affecting women residing in Western countries and is
the second leading cause of death [56]. The general popula-
tion is exposed to several hormonally active compounds on a
daily basis. The majority of these compounds are xenoestro-
gens (e.g., PCAHs, pesticides, PCBs, PBDEs, DDT, selected
drugs, fungicides, phytoestrogens, mycotoxins, BPA, and
phthalates), and they can possess estrogenic action, affect
estrogen levels, and/or bind to ERs [57].
4.1.1. Recent Findings on PCBs. The role of PCBs in breast
cancer has been investigated intensively. Data suggest that a
correlation may exist between high levels of PCBs in mam-
mary tissues or sera and breast cancer risk [58], while another
study reported no association [59]. High PCB levels upregu-
lated CYP expression [60], suggesting that PCB metabolites
may be critical for the pathogenesis of breast cancer. Likewise,
Pang and colleagues [61] reported that exposure of MCF-7
human breast cancer cells to PCBs 81, 126, and 39 increased
CYP1A1 andCYP1B1mRNA levels, resulting in the formation
of E2 metabolites. We demonstrated PCB 3 to induce and to
be a substrate for CYP1A1in MCF-7 cells [62]. On the other
hand, others have shown PCBs 52 and 77 to induce oxidative
damage (i.e., DNA strand breaks) in ER𝛼 (−)/MDA breast
cancer cells but not in ER𝛼 (+)/MCF-7 cells [63], suggesting
that the ER𝛼 receptormay play a protective role in breast can-
cer. Moreover, PCBs can interfere with the balance between
proliferation and apoptosis. Radice et al. [64] demonstrated
those PCB congeners such as PCBs 101, 118, 138, 153, and
180 increased proliferations of MCF-7 cells. Our published
data demonstrated that from investigated congeners (118, 138,
153, and 180), PCB138 and 153 had the highest stimulatory
effects on basal MCF-7 cell proliferation as well as the highest
inhibitory actions on basal caspase-9 activity. Moreover, we
showed that PCBs 138 and 153 contribute to the action of
endogenous 17𝛽-estradiol on cell proliferation and apoptosis
in the breast cancer cell line MCF-7 [65]. In vivo experiments
have also shown PCBs to increasemetastasis by triggering the
production of reactive oxygen species (ROS), thereby acti-
vating the Rho-associated protein kinase (ROCK) signaling
pathway [66] or vascular endothelial growth factor (VEGF)
overexpression that stimulates endothelial hyperpermeability
and transendothelial migration of cancer cells [67].
4.1.2. Recent Findings on PBDEs. Data on the effects of PBDEs
on breast cancer are scant. PBDEs trigger micronucleus for-
mation and proliferation in MCF-7 cells [68]. An increase
in MCF-7 cell proliferation by DE-71 (a mixture of BDE-
47, -99, -100, -153, and -154) was also reported by Mercado-
Feliciano and Bigsby [69]. PBDE-209 also induced MCF-7
cell proliferation by affecting critical steps of the cell cycle
[70]. At the molecular level, PBDE-209 triggered protein
kinase C 𝛼 (PKC𝛼) and ERK1/2 phosphorylation. On the
other hand, Kwiecińska et al. [71] have shown no changes in
MCF-7 cell proliferation following exposure to BDE-47, -99, -
100, and -209; however, apoptosis was inhibited by decreasing
caspase-9 activity in these cells [71]. Resistance to apoptosis
associates with tumorigenesis as it enables tumorigenic cells
to expand even in a stressful environment. Thus, additional
studies are needed to determine if exposure to PBDEs can
indeed cause breast cancer.
4.1.3. Recent Findings on Bisphenol A (BPA). Laboratory
studies in rodents suggest a link between BPA exposure and
breast cancer incidence. When rodents were exposed to BPA
early in life, there were changes in mammary gland morpho-
genesis and tumor susceptibility [72–74]. These findings are
supported by in vitro data which demonstrated BPA to induce
transformation of MCF-10F human breast cancer cells. These
cells formed tubule-like structures when cultured in 3D
collagen matrix, but spherical masses were noted after BPA
treatment [75], leading the authors to conclude that BPA
produces adducts or ROS which can inadvertently introduce
a variety of DNAmodifications and cause breast cancer. Oth-
ers have shown BPA to stimulate proliferation but to inhibit
apoptosis inMCF-7 cells [76–78]. BPAmay also induce breast
cancer cell proliferation by upregulating cell cycle genes and
downregulating antiproliferative genes, especially genes that
control the G1/S transition via ER𝛼 signaling [79].
4.2. Ovarian Cancer. Ovarian cancer is the most prevalent
type of gynecological cancer affecting women residing in
Western countries. As more than 60% of tumors are diag-
nosed at stage III and certain forms of cancer are very aggres-
sive, ovarian cancers are associated with a high mortality.
While most cells undergo neoplastic transformation, includ-
ing germ cells, granulose, and stromal cells, approximately
90% of tumors are derived from the ovarian surface epithe-
lium (OSE). Similar to breast cancer, hormonal factors such
as estrogen and xenoestrogens have been linked to ovarian
cancer [80, 81]; however, the role of environmental toxicants
in ovarian cancer requires further study.
4.2.1. Recent Findings on PCBs and PBDEs. The role of
PCBs in the initiation and progression of ovarian cancer is
unknown. Studies in adult C57BL mice showed that orally
administered PBDEs-47, -85, and -99 to accumulate in the
liver, adrenal cortex, and ovary in adult C57BL mice [82]
suggest a possible carcinogenic activity, especially in light of
research showing that exposure of CHO and OVCAR-3 cells
to PBDE-209 initiated S and G2/M phases of the cell cycle,
respectively [83].
4.2.2. Recent Findings on BPA. Several in vitro studies have
shown BPA to induce chromosomal aberrations in CHO cells
[84, 85], a common genetic alteration in cancer. Moreover,
ovarian cyst formation was observed in mice treated neona-
tally with BPA [86]. Ovarian cancer may stem from incessant
ovulation, which may be linked to the formation of cysts
that are frequently found in perimenopausal women. In a
study from our laboratory, we demonstrated an increase in
proliferation inOVCAR- 3 cells treatedwithBPA. Specifically,
we showed BPA to promote the cell cycle by upregulating
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the expression of cyclin D1, CDK4, E2F1, E2F3, and PCNA
(a mediator of G1 to S-phase progression) and cyclin A (a
mediator of G2-phase progression to mitosis), but by down-
regulating the expression of p21WAF1/CIP1, Weel-1, and
GADD45𝛼 [87]. Additionally, we demonstrated a decrease
in the expression of proapoptotic genes (i.e., FAS, FADD,
RAIDD, caspase-8, -10, -3, -6, and 7, CAD, Bax, Bak, Bok,
and Apaf-1) but an increase in the expression of prosurvival
genes (i.e., Bcl-x and Mcl-1). BPA also activates a caspases-
independent apoptotic pathway by inducing endonuclease G
gene expression. Also, Hwang et al. [88] using microarray
analysis increased mRNA levels of E2-responsive genes in
ER-positive ovarian cancer BG-1 cells under the influence
of BPA. In a subsequent study, we showed BPA to trigger
phosphorylation of Stat3, ERK1/2, and Akt in OVCAR-3
cells [89]. Cited results of research indicated that BPA acting
as a mitogen as well as an antiapoptotic factor may be an
additional factor responsible for ovarian cancer.
5. Conclusions
In recent years there has been a growing evidence that expo-
sure to chemicals in the environment poses a serious threat
to human and animals reproduction via disrupting effects
on endocrine function. Despite the fact that these substances
are persistent, they may be metabolized into more toxic
compounds than the parent molecule in endocrine organs.
This endocrine disrupting chemicals (EDCs) adversely affect
health and reproduction even at very low concentrations and
may exert their effects on the embryo and fetus.The complex-
ity and diversity of factors belonging to EDCs, its direct action
on the ovary, and disorders of the reproductive function of
women indicate that the impact of environmental pollution
as an important determinant factor in fertility should not
be minimize. Current estimates of cancer risk in humans do
not account properly for transplacental and environmental
(including occupational) exposure to xenoestrogens. It is
important to reevaluate the role of xenoestrogens in cancer
development using new approaches that better reflect the
complexity of carcinogenesis. Testing new compounds before
they are allowed to use should be expanded to determine
their effect on the endocrine system, in order to assess the
hormonal activity. In addition, attention should be directed
towards dose-response relationships in environmental tox-
icology. Such studies can provide useful information that
might have a significant impact on the strategies for risk
assessment of toxic substances.
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U. Skaare, andE. Ropstad, “Steroid secretion following exposure
of ovarian follicular cells to three different natural mixtures of
persistent organic pollutants (POPs),” Reproductive Toxicology,
vol. 25, no. 1, pp. 58–66, 2008.
[16] BSEF, “Bromine science and enviromental forum,” 2007, http://
www.bsef.com/.
[17] K. Akutsu and S. Hori, “Polybrominated diphenyl ether flame
retardants in foodstuffs and human milk,” Shokuhin Eiseigaku
Zasshi, vol. 45, no. 4, pp. 175–183, 2004.
[18] I. A. T. M. Meerts, R. J. Letcher, S. Hoving et al., “In vitro
estrogenicity of polybrominated diphenyl ethers, hydroxylated
PBDEs, and polybrominated bisphenol A compounds,” Envi-
ronmental Health Perspectives, vol. 109, no. 4, pp. 399–407, 2001.
[19] A. Sjodin, D. G. Patterson Jr., and A. Bergman, “A review on
human exposure to brominated flame retardants—particularly
polybrominated diphenyl ethers,” Environment International,
vol. 29, no. 6, pp. 829–839, 2003.
[20] T. Zhou, M. M. Taylor, M. J. De Vito, and K. M. Crofton,
“Developmental exposure to brominated diphenyl ethers results
in thyroid hormone disruption,” Toxicological Sciences, vol. 66,
no. 1, pp. 105–116, 2002.
[21] T. E. Stoker, S. C. Laws, K. M. Crofton, J. M. Hedge, J. M.
Ferrell, and R. L. Cooper, “Assessment of DE-71, a commercial
polybrominated diphenyl ether (PBDE) mixture, in the EDSP
male and female pubertal protocols,” Toxicological Sciences, vol.
78, no. 1, pp. 144–155, 2004.
[22] A. Karpeta and E. L. Gregoraszczuk, “Mixture of dominant
PBDE congeners (BDE-47, -99, -100 and -209) at levels noted
in human blood dramatically enhances progesterone secretion
by ovarian follicles,” Endocrine Regulations, vol. 44, no. 2, pp.
49–55, 2010.
[23] A. Karpeta, A. Rak-Mardyła, J. Jerzak, and E. L. Gregoraszczuk,
“Congener-specific action of PBDEs on steroid secretion,
CYP17, 17𝛽-HSD and CYP19 activity and protein expression in
porcine ovarian follicles,” Toxicology Letters, vol. 206, pp. 258–
263, 2011.
[24] A. Karpeta, K. Warzecha, J. Jerzak, A. Ptak, and E. L. Grego-
raszczuk, “Activation of the enzymes of phase I, (CYP2B1/2)
and phase II, (SULT1A and COMT) metabolism by 2, 2󸀠, 4, 4󸀠-
tetrabromodiphenyl ether (BDE47) in the pig ovary,” Reproduc-
tive Toxicology, vol. 34, pp. 436–442, 2012.
[25] A. Karpeta, J. Barc, and A. Ptak, “Gregoraszczuk EL.The 2, 2󸀠, 4,
4󸀠-tetrabromodiphenyl ether hydroxylated metabolites 5-OH-
BDE-47 and 6-OH-BDE-47 stimulate estradiol secretion in the
ovary by activating aromatase expression,” Toxicology, vol. 305,
pp. 65–70, 2013.
[26] J. Falandysz, “Chloronaphthalenes as food-chain contaminants:
a review,” Food Additives and Contaminants, vol. 21, pp. 995–
1014, 2003.
[27] A. L. Blankenship, K. Kannan, S. A. Villalobos et al., “Rela-
tive potencies of individual polychlorinated naphthalenes and
halowax mixtures to induce Ah receptor-mediated responses,”
Environmental Science and Technology, vol. 34, no. 15, pp. 3153–
3158, 2000.
[28] D. L. Villeneuve, K. Kannan, J. S. Khim et al., “Relative potencies
of individual polychlorinated naphthalenes to induce dioxin-
like responses in fish and mammalian in vitro bioassays,”
Archives of Environmental Contamination and Toxicology, vol.
39, no. 3, pp. 273–281, 2000.
[29] E. Ł. Gregoraszczuk, J. Jerzak, A. Rak-Mardyła, and J. Falandysz,
“Halowax 1051 affects steroidogenesis, 17𝛽-hydroxysteroid
dehydrogenase (17𝛽-HSD) and cytochrome P450arom (CYP19)
activity, and protein expression in porcine ovarian follicles,”
Reproductive Toxicology, vol. 32, pp. 379–384, 2011.
[30] J. Barc, A. Karpeta, and E. L. Gregoraszczuk, “Action of halowax
1051 on enzymes of phase I, (CYP1A1) and phase II, (SULT1A
and COMT)metabolism in the pig ovary,” International Journal
of Endocrinology, vol. 2013, Article ID 590261, 7 pages, 2013.
[31] J. F. Jarrell, A. Gocmen, D. Akyol, and R. Brant, “Hexachlorob-
enzene exposure and the proportion of male births in Turkey
1935–1990,” Reproductive Toxicology, vol. 16, no. 1, pp. 65–70,
2002.
[32] N. Khanjani and M. R. Sim, “Reproductive outcomes of
maternal contamination with cyclodiene insecticides, hex-
achlorobenzene and 𝛽-benzene hexachloride,” Science of the
Total Environment, vol. 368, no. 2-3, pp. 557–564, 2006.
[33] L. Alvarez, A. Randi, P. Alvarez et al., “Reproductive effects of
hexachlorobenzene in female rats,” Journal of Applied Toxicol-
ogy, vol. 20, pp. 81–87, 2000.
[34] W. G. Foster, J. A. Pentick, A. McMahon, and P. R. Lecavalier,
“Ovarian toxicity of hexachlorobenzene (HCB) in the super-
ovulated female rat,” Journal of Biochemical Toxicology, vol. 7,
no. 1, pp. 1–4, 1992.
[35] E. Ł. Gregoraszczuk, A. Ptak, A. Rak-Mardyła, and J. Falandysz,
“Differential accumulation of HCBz and PeCBz in porcine
ovarian follicles and their opposing actions on steroid secretion
and CYP11, CYP17, 17𝛽-HSD and CYP19 protein expression. A
tissue culture approach,” Reproductive Toxicology, vol. 31, no. 4,
pp. 494–499, 2011.
[36] E. V. Younglai, W. G. Foster, E. G. Hughes, K. Trim, and J. F.
Jarrell, “Levels of environmental contaminants in human follic-
ular fluid, serum, and seminal plasma of couples undergoing
in vitro fertilization,” Archives of Environmental Contamination
and Toxicology, vol. 43, no. 1, pp. 121–126, 2002.
[37] K. Ramamoorthy, C. Vyhlidal, F. Wang et al., “Additive estro-
genic activities of a binary mixture of 2󸀠,4󸀠,6󸀠-Trichloro- and
2󸀠,3󸀠,4󸀠,5󸀠-tetrachloro-4-biphenylol,” Toxicology and Applied
Pharmacology, vol. 147, no. 1, pp. 93–100, 1997.
[38] K. C. Donnelly, L. D. Claxton, H. J. Huebner, and J. L. Capizzi,
“Mutagenic interactions of model chemical mixtures,” Chemo-
sphere, vol. 37, no. 7, pp. 1253–1261, 1998.
[39] S. A. Andric, T. S. Kostic, S. S. Stojilkovic, and R. Z. Kovacevic,
“Inhibition of rat testicular androgenesis by a polychlorinated
biphenylmixtureAroclor 1248,”Biology of Reproduction, vol. 62,
no. 6, pp. 1882–1888, 2000.
[40] E. J. Calabrese and L. A. Baldwin, “Hormesis: U-shaped dose
responses and their centrality in toxicology,” Trends in Pharma-
cological Sciences, vol. 22, no. 6, pp. 285–291, 2001.
[41] D. O. Carpenter, K. Arcaro, and D. C. Spink, “Understanding
the human health effects of chemical mixtures,” Environmental
Health Perspectives, vol. 110, no. 1, pp. 25–42, 2002.
[42] E. L. Gregoraszczuk, A. Ptak, M. Karniewska, and E. Ropstad,
“Action of definedmixtures of PCBs, p,p󸀠-DDT and its metabo-
lite p,p󸀠-DDE, on co-culture of porcine theca and granulosa
cells: steroid secretion, cell proliferation and apoptosis,” Repro-
ductive Toxicology, vol. 26, no. 2, pp. 170–174, 2008.
[43] E. Ł. Gregoraszczuk, A. Rak, K. Kawalec, and E. Ropstad,
“Steroid secretion following exposure of ovarian follicular cells
to single congeners and defined mixture of polybrominated-
dibenzoethers (PBDEs), p,p󸀠-DDT and its metabolite p,p󸀠-
DDE,” Toxicology Letters, vol. 178, no. 2, pp. 103–109, 2008.
[44] E. L. Gregoraszczuk, A. Ptak, J. U. Skaare et al., “Mechanisms
of action of two different natural mixtures of persistent organic
8 International Journal of Endocrinology
pollutants (POPs) in ovarian follicles,” Xenobiotica, vol. 39, no.
1, pp. 80–89, 2009.
[45] E. Diamanti-Kandarakis, J. P. Bourguignon, L. C. Giudice et al.,
“Endocrine-disrupting chemicals: an endocrine society scien-
tific statement,” Endocrine Reviews, vol. 30, no. 4, pp. 293–342,
2009.
[46] E. Den Hond, G. Schoeters, W. G. Sippell et al., “Endocrine dis-
rupters and human puberty,” International Journal of Andrology,
vol. 29, no. 1, pp. 264–271, 2006.
[47] I. Colón,D.Caro, C. J. Bourdony, andO.Rosario, “Identification
of phthalate esters in the serum of young Puerto Rican girls
with premature breast development,” Environmental Health
Perspectives, vol. 108, no. 9, pp. 895–900, 2000.
[48] M. Krstevska-Konstantinova, C. Charlier, M. Craen et al.,
“Sexual precocity after immigration from developing countries
to Belgium: evidence of previous exposure to organochlorine
pesticides,” Human Reproduction, vol. 16, no. 5, pp. 1020–1026,
2001.
[49] T. Takeuchi, O. Tsutsumi, Y. Ikezuki, Y. Takai, and Y. Taketani,
“Positive relationship between androgen and the endocrine
disruptor, bisphenol A, in normal women and women with
ovarian dysfunction,” Endocrine Journal, vol. 51, no. 2, pp. 165–
169, 2004.
[50] T. Takeuchi, O. Tsutsumi, Y. Ikezuki et al., “Elevated serum
bisphenol A levels under hyperandrogenic conditions may
be caused by decreased UDP-glucuronosyltransferase activity,”
Endocrine Journal, vol. 53, no. 4, pp. 485–491, 2006.
[51] P. Sinha and N. Kuruba, “Premature ovarian failure,” Journal of
Obstetrics and Gynaecology, vol. 27, no. 1, pp. 16–19, 2007.
[52] P. A. Hunt, K. E. Koehler, M. Susiarjo et al., “Bisphenol a
exposure causes meiotic aneuploidy in the female mouse,”
Current Biology, vol. 13, no. 7, pp. 546–553, 2003.
[53] M. Susiarjo, T. J. Hassold, E. Freeman, and P. A. Hunt, “Bisphe-
nol A exposure in utero disrupts early oogenesis in the mouse,”
PLoS Genetics, vol. 3, no. 1, article e5, 2007.
[54] S. J. Genuis, “Health issues and the environment-an emerging
paradigm for providers of obstetrical and gynaecological health
care,” Human Reproduction, vol. 21, pp. 2201–2208, 2006.
[55] Z. Shi, K. E. Valdez, A. Y. Ting, A. Franczak, S. L. Gum, and B.
K. Petroff, “Ovarian endocrine disruption underlies premature
reproductive senescence following environmentally relevant
chronic exposure to the aryl hydrocarbon receptor agonist
2,3,7,8-tetrachlorodibenzo-p-dioxin,” Biology of Reproduction,
vol. 76, no. 2, pp. 198–202, 2007.
[56] J. V. Lacey Jr., S. S. Devesa, and L. A. Brinton, “Recent trends
in breast cancer incidence and mortality,” Environmental and
Molecular Mutagenesis, vol. 39, no. 2-3, pp. 82–88, 2002.
[57] I. A. T. M. Meerts, R. J. Letcher, S. Hoving et al., “In vitro
estrogenicity of polybrominated diphenyl ethers, hydroxylated
PBDEs, and polybrominated bisphenol A compounds,” Envi-
ronmental Health Perspectives, vol. 109, no. 4, pp. 399–407, 2001.
[58] R. Recio-Vega, V. Velazco-Rodriguez, G. Ocampo-Gómez, S.
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